Key result
Intravenous haloperidol effectively manages agitated delirium in critically ill cardiac patients requiring IABP support.
Why the study?
Delirium associated with use of the intra-aortic balloon pump in critically ill cardiac patients requires effective pharmacologic treatment strategies.
Does intravenous haloperidol effectively manage agitated delirium in critically ill cardiac patients with an intra-aortic balloon pump?
Does intravenous haloperidol effectively manage agitated delirium in critically ill cardiac patients with an intra-aortic balloon pump?
Intravenous haloperidol may be an effective strategy for managing agitated delirium in critically ill cardiac patients requiring an intra-aortic balloon pump.
May support haloperidol for IABP-associated delirium; leaves open need for randomized confirmation.
Five patients who developed an agitated delirium in association with use of an intra-aortic balloon pump are presented. The differential diagnosis of delirium in critically ill cardiac patients is reviewed and effective pharmacologic treatment strategies (involving rapid and aggressive management with intravenous haloperidol) are discussed.
No takes yet. Share an insight, caveat, or question.
Sanders et al. (1993) studied this question. Intravenous haloperidol provides effective pharmacologic management for agitated delirium associated with intra-aortic balloon pump use in critically ill cardiac patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: